TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2121016

Group type: EXPERIMENTAL
Intervention: Recombinant tissue-type plasminogen activator (rt-PA) followed by heparin
Number of subjects: 103

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 103
Study: 526908

Group type: EXPERIMENTAL
Intervention: Rubidazone (150 mg/m2 iv over 1 hour)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Adriamycin (60 mg/m2 iv over 5 minutes)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Adriamycin (60 mg/m2 iv over 5 minutes) after rubidazone failure
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Rubidazone
Number of subjects: 38

Group type: COMPARATOR
Intervention: Adriamycin
Number of subjects: 38
Study: 30552157

Group type: EXPERIMENTAL
Intervention: cFOLFOXIRI-BEV
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: sFOLFOXIRI-BEV
Number of subjects: 280

Group type: COMPARATOR
Intervention: FOLFOX-BEV
Number of subjects: 280
Study: 27178566

Group type: EXPERIMENTAL
Intervention: Dual-coated probiotics (Duolac Care), 2 capsules per day, 5 billion bacteria per capsule for 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-coated probiotics
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dual-coated probiotics
Number of subjects: 50
Study: 25607519

Group type: EXPERIMENTAL
Intervention: Supplement (vitamin C:1000mg/d; vitamin E: 400 IU/d)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 23782628

Group type: EXPERIMENTAL
Intervention: Tongue Pressure Profile Training (TPPT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tongue Pressure Strength-and-Accuracy Training (TPSAT)
Number of subjects: 60
Study: 21648052

Group type: EXPERIMENTAL
Intervention: Bare metal renal artery stenting
Number of subjects: 286
Study: 19229549

Group type: EXPERIMENTAL
Intervention: Carbetocin (100 microg IV injection)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Oxytocin (10 IU IV infusion over 2 hours)
Number of subjects: 104
Study: 16508386

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib 40 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 30 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Preservative-free normal saline (placebo)
Number of subjects: 30
Study: 12871368

Group type: EXPERIMENTAL
Intervention: Ximelagatran 20 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ximelagatran 40 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ximelagatran 80 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: r-Hirudin
Number of subjects: 60
Study: 11908372

Group type: EXPERIMENTAL
Intervention: Colgate Actibrush battery‐powered toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dr. Best Flex Toothbrush (Germany)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reach Triple Action Ultra Clean Toothbrush (Germany)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Jordan Multi‐Action Toothbrush (Norway)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sanogyl Systeme In'Side Double Action Toothbrush (France)
Number of subjects: 0
Study: 8932891

Group type: EXPERIMENTAL
Intervention: Glycine (0.8 g/kg body weight/day)
Number of subjects: 11
Study: 1415392

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Terbutaline (5 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 4064532

Group type: EXPERIMENTAL
Intervention: Buscopan (20 mg)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Glucagon (0.5 mg)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 114
Study: 31830962

Group type: EXPERIMENTAL
Intervention: Biased vignettes (patients with schizophrenia or free care recipients)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Neutral vignettes (no additional patient information)
Number of subjects: 207
Study: 28419778

Group type: EXPERIMENTAL
Intervention: Raltegravir 600 mg formulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raltegravir 3 × 400 mg and 2 × 600 mg dosage forms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raltegravir 2 × 600 mg formulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raltegravir 1200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raltegravir multiple doses
Number of subjects: 0
Study: 27192633

Group type: EXPERIMENTAL
Intervention: Weight lifting intervention
Number of subjects: 281
Study: 24119859

Group type: EXPERIMENTAL
Intervention: Humor therapy intervention provided by ElderClowns for 2-hour sessions, 9-12 times over 12 weeks.
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Humor therapy intervention
Number of subjects: 189
Study: 22249997

Group type: EXPERIMENTAL
Intervention: Ecosystem Focused Therapy (EFT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Education on Stroke and Depression
Number of subjects: 24
Study: 20165744

Group type: EXPERIMENTAL
Intervention: OFD+EMP
Number of subjects: 10

Group type: COMPARATOR
Intervention: OFD
Number of subjects: 10
Study: 18062519

Group type: EXPERIMENTAL
Intervention: Propofol mixed with 2cc of a solution containing phenylephrine 100 microg/cc (total 100 microg)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Propofol mixed with 2cc of a solution containing phenylephrine 50 microg/cc (total 50 microg)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Propofol mixed with 2cc of 0.9% normal saline
Number of subjects: 135
Study: 16173386

Group type: EXPERIMENTAL
Intervention: Combined preventive-operative method including ART-fissure sealant/restoration and fluoride varnish application (test group)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combined preventive-operative method (test group)
Number of subjects: 27
Study: 12068252

Group type: COMPARATOR
Intervention: Clinical routine alone
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: CAGE questionnaire added
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Addition of GGT
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Addition of CDT
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Combination of all tests
Number of subjects: 705
Study: 10913815

Group type: EXPERIMENTAL
Intervention: Radial artery
Number of subjects: 464

Group type: COMPARATOR
Intervention: Saphenous vein
Number of subjects: 464
Study: 8873695

Group type: EXPERIMENTAL
Intervention: 10 mg benazepril
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 20 mg nicardipine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (placebo run-in period)
Number of subjects: 103
Study: 1742901

Group type: EXPERIMENTAL
Intervention: Clindamycin, 150 mg 4 times daily for 10 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: No antibiotic treatment (Control)
Number of subjects: 54
Study: 6743780

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Trimipramine (50 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg) + Trimipramine (50 mg)
Number of subjects: 10
Study: 31404936

Group type: EXPERIMENTAL
Intervention: Plyometric training for 12 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (continued own training methods)
Number of subjects: 42
Study: 28870242

Group type: EXPERIMENTAL
Intervention: Intraoperative wound irrigation with 0.04% polyhexanide (PHX) solution
Number of subjects: 540

Group type: COMPARATOR
Intervention: No irrigation (control group)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Saline irrigation (control group)
Number of subjects: 540
Study: 26152221

Group type: EXPERIMENTAL
Intervention: Insulin intensive therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group with continuation of pre‐CR antidiabetic treatment
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Good glycemic control (final fructosamine level below median)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Poor glycemic control (final fructosamine level above median)
Number of subjects: 64
Study: 22921159

Group type: EXPERIMENTAL
Intervention: Health information package (validated planned educational programme with visual aids and iron supplementation)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group A (iron supplementation only)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group B (iron supplementation only)
Number of subjects: 225
Study: 21272979

Group type: EXPERIMENTAL
Intervention: Autogenous graft
Number of subjects: 26

Group type: COMPARATOR
Intervention: Medpor
Number of subjects: 26
Study: 18481722

Group type: EXPERIMENTAL
Intervention: Improved thunder-fire miraculous needle
Number of subjects: 117

Group type: COMPARATOR
Intervention: Pressing and moxibustion at Baihui (GV 20)
Number of subjects: 117
Study: 16290094

Group type: EXPERIMENTAL
Intervention: GP educational outreach visiting
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Structured patient and caregiver educational outreach visiting
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Coordinated palliative care model of case conferencing
Number of subjects: 461

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 461

Group type: COMPARATOR
Intervention: Standard model of palliative care
Number of subjects: 461
Study: 15567112

Group type: EXPERIMENTAL
Intervention: Night Eating Syndrome Questionnaire (NESQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Night eating screening question
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment outcomes (adherence and weight loss)
Number of subjects: 0
Study: 11068858

Group type: EXPERIMENTAL
Intervention: 2 x weekly narrow-band UVB treatment
Number of subjects: 69

Group type: COMPARATOR
Intervention: 4 x weekly narrow-band UVB treatment
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 69
Study: 9313738

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging
Number of subjects: 20

Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 20
Study: 8329785

Group type: EXPERIMENTAL
Intervention: Flavored Colestid Granules in water
Number of subjects: 72

Group type: COMPARATOR
Intervention: Questran Light in orange juice
Number of subjects: 72
Study: 2439786

Group type: EXPERIMENTAL
Intervention: 5 mg bisoprolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg bisoprolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 20 mg bisoprolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bisoprolol (all doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bisoprolol (20 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg and 20 mg)
Number of subjects: 12
Study: 2738457

Group type: EXPERIMENTAL
Intervention: Sensory Integrative Therapy (SIT) program
Number of subjects: 55

Group type: COMPARATOR
Intervention: Parallel physical education program
Number of subjects: 55

Group type: COMPARATOR
Intervention: No-treatment condition
Number of subjects: 55
Study: 31740348

Group type: EXPERIMENTAL
Intervention: Doravirine (100 mg per day)
Number of subjects: 769

Group type: COMPARATOR
Intervention: Ritonavir-boosted darunavir (100 mg ritonavir and 800 mg darunavir per day)
Number of subjects: 769

Group type: EXPERIMENTAL
Intervention: Doravirine
Number of subjects: 769

Group type: COMPARATOR
Intervention: Ritonavir-boosted darunavir
Number of subjects: 769
Study: 29843517

Group type: EXPERIMENTAL
Intervention: Instructional and educational stroke DVD intervention over six weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 66
Study: 27627647

Group type: EXPERIMENTAL
Intervention: Green tea gargling
Number of subjects: 747

Group type: COMPARATOR
Intervention: Water gargling (control)
Number of subjects: 747
Study: 26165919

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural suicide prevention (CBSP) therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 62
Study: 23943299

Group type: EXPERIMENTAL
Intervention: Hormonal therapy (HT)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Deferred hormonal therapy (D(HT))
Number of subjects: 228

Group type: COMPARATOR
Intervention: Chemotherapy (CHT)
Number of subjects: 228
Study: 21930653

Group type: EXPERIMENTAL
Intervention: Group 1 (no AF recurrences during the 3-month postablation period)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Group 3 (treated only with antiarrhythmic drugs for 6 weeks)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Group 4 (treated according to the onset mechanism of AF recurrences)
Number of subjects: 286
Study: 18985146

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (desipramine or fluoxetine) for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 16870913

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (20 ppm, decreasing concentrations for a minimum of 24 days)
Number of subjects: 582

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide
Number of subjects: 582
Study: 15630774

Group type: EXPERIMENTAL
Intervention: One-on-one teaching
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Group teaching
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 11377900

Group type: EXPERIMENTAL
Intervention: Fixed dorzolamide-timolol combination
Number of subjects: 30

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 30
Study: 9243107

Group type: EXPERIMENTAL
Intervention: Oral 17 beta-estradiol for 6 weeks
Number of subjects: 40
Study: 8500516

Group type: EXPERIMENTAL
Intervention: Pravastatin (n = 34)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (n = 17)
Number of subjects: 51
Study: 3448453

Group type: EXPERIMENTAL
Intervention: Microencapsulated formulation (C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Highly buffered formulation (A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytoprotective formulation (B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain tablet formulation (D)
Number of subjects: 0
Study: 31669966

Group type: EXPERIMENTAL
Intervention: High‐fidelity simulator
Number of subjects: 72

Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 72
Study: 30224402

Group type: EXPERIMENTAL
Intervention: Adults living with HIV
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Increasing depressive scores in adults living with HIV
Number of subjects: 84

Group type: COMPARATOR
Intervention: Community controls
Number of subjects: 84
Study: 27565270

Group type: EXPERIMENTAL
Intervention: ICS + LABA treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: ICS + LTRA treatment
Number of subjects: 0
Study: 25335330

Group type: EXPERIMENTAL
Intervention: Yishen Jiejing Decoction (YJD), 50 mL, twice a day for one month
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional rehabilitation training and therapeutics
Number of subjects: 60
Study: 23050578

Group type: EXPERIMENTAL
Intervention: Nurse-led empowerment-based intervention (eight weekly sessions including lifestyle modification education, empowerment group discussions, and exercise training)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard hypertension care (control group)
Number of subjects: 52
Study: 20444135

Group type: EXPERIMENTAL
Intervention: Monovision correction contact lenses
Number of subjects: 11

Group type: COMPARATOR
Intervention: Distance correction contact lenses
Number of subjects: 11
Study: 18716496

Group type: EXPERIMENTAL
Intervention: Women with low back pain
Number of subjects: 1342

Group type: COMPARATOR
Intervention: Healthcare services utilization
Number of subjects: 1342
Study: 16758849

Group type: EXPERIMENTAL
Intervention: Hypertonic-hyperoncotic solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isotonic solution
Number of subjects: 40
Study: 12638028

Group type: EXPERIMENTAL
Intervention: High-carbohydrates (HC) diet (65E% carbohydrates, 20E% fat)
Number of subjects: 7

Group type: COMPARATOR
Intervention: High-fat (HF) diet (40E% carbohydrates, 45E% fat)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Meal intake at various times (0800, 1200, 0400, 1600, 2000, 0000 h)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Postprandial increase of pancreatic polypeptide (PP)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Endocrine responses (glucagon, TSH, fT4, tT3, cortisol, CgA, PP)
Number of subjects: 7
Study: 11094863

Group type: EXPERIMENTAL
Intervention: High-protein, very low-calorie diet (VLCD; protein intake 1.5 to 2.0 g/kg of ideal body weight per day; 800 kcal/d) with weekly 2-hour clinic sessions including nutrition instruction, moderate-intensity exercise, and behavior-modification techniques.
Number of subjects: 11
Study: 9549286

Group type: EXPERIMENTAL
Intervention: Endarterectomy (EA) of SFAs with Self‐Expanding Coated Stent (Meadox Passager 6‐10 mm) implantation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Endarterectomy (EA) of SFAs with a 5 mm diameter thin‐walled PTFE endoluminal graft using a Strecker stent for distal fixation
Number of subjects: 4
Study: 8230016

Group type: EXPERIMENTAL
Intervention: Resistive exercise
Number of subjects: 5

Group type: COMPARATOR
Intervention: Nonresistive exercise
Number of subjects: 5
Study: 3086721

Group type: EXPERIMENTAL
Intervention: 125 mg of penicillin V potassium twice daily
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study: 31441895

Group type: EXPERIMENTAL
Intervention: Juglandis semen complex extract (JCE) 1000 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Juglandis semen complex extract (JCE) 2000 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27742871

Group type: EXPERIMENTAL
Intervention: Salbutamol (400 µg)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 720
Study: 25684164

Group type: EXPERIMENTAL
Intervention: Antiplatelet treatment (126 participants)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Anticoagulant treatment (124 participants)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Antiplatelet treatment (101 participants, per-protocol analysis)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Anticoagulant treatment (96 participants, per-protocol analysis)
Number of subjects: 250
Study: 23834479

Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 268

Group type: COMPARATOR
Intervention: Cinacalcet plus low-dose vitamin D
Number of subjects: 268
Study: 21962214

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (500 mg/kg)
Number of subjects: 3493

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3493
Study: 19522023

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 17591349

Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) intervention including health education, identification, and referral of sick newborns.
Number of subjects: 0
Study: 15533561

Group type: EXPERIMENTAL
Intervention: Pharyngeal flap
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sphincter pharyngoplasty
Number of subjects: 70
Study: 11389271

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-impregnated dressing (Biopatch Antimicrobial Dressing)
Number of subjects: 705

Group type: COMPARATOR
Intervention: 10% povidone-iodine (PI) skin scrub
Number of subjects: 705
Study: 10193284

Group type: EXPERIMENTAL
Intervention: Pre‐emptive local anaesthetic block using 0.5% bupivacaine, together with i.v. tenoxicam and alfentanil
Number of subjects: 32

Group type: COMPARATOR
Intervention: Postoperative administration of analgesia
Number of subjects: 32
Study: 7880351

Group type: EXPERIMENTAL
Intervention: Optical Catheter System (OCS)
Number of subjects: 50
Study: 3207528

Group type: EXPERIMENTAL
Intervention: Low-dose fentanyl anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose fentanyl anaesthesia
Number of subjects: 0
Study: 29447769

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 7391

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7391
Study: 28679435

Group type: EXPERIMENTAL
Intervention: Light physical activity of healthy weight fathers at age 3.5 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate/vigorous physical activity of fathers at age 5 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical activity levels of fathers and children at age 20 months
Number of subjects: 0
Study: 25701437

Group type: EXPERIMENTAL
Intervention: Online program consisting of four interactive modules for communication skills training.
Number of subjects: 0
Study: 23550526

Group type: EXPERIMENTAL
Intervention: New Beginnings program (attachment-based group intervention)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 163
Study: 22048557

Group type: EXPERIMENTAL
Intervention: Educational intervention based on self-efficacy theory
Number of subjects: 110

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 110
Study: 19622687

Group type: COMPARATOR
Intervention: EEG spectral power in alpha2, delta, and theta bands
Number of subjects: 28

Group type: COMPARATOR
Intervention: EEG spectral power in alpha1, alpha2, delta, and theta bands
Number of subjects: 28
Study: 16470086

Group type: EXPERIMENTAL
Intervention: 800 mg oral magnesium oxide daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 15009817

Group type: EXPERIMENTAL
Intervention: Low-dose clonidine (25 micro g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Medium-dose clonidine (150 micro g)
Number of subjects: 15
Study: 10968501

Group type: EXPERIMENTAL
Intervention: Salbutamol (100 microg x puff(‐1)) via metered-dose inhaler (MDI) under pressure control (decelerating flow pattern)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Salbutamol (200 microg) via MDI under volume control (square wave flow pattern)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Salbutamol (600 microg) via MDI under volume control (square wave flow pattern)
Number of subjects: 18
Study: 9247980

Group type: EXPERIMENTAL
Intervention: Inhalation of 35% CO2 gas mixture
Number of subjects: 68

Group type: COMPARATOR
Intervention: Inhalation of compressed air (control)
Number of subjects: 68